Literature DB >> 27022940

SIRT1 prevents hyperuricemia via the PGC-1α/PPARγ-ABCG2 pathway.

Juan Wang1,2, Xiao-Xia Zhu3,4, Lei Liu1,2, Yu Xue1,2, Xue Yang1,2, He-Jian Zou5,6.   

Abstract

Silent information regulator T1 (SIRT1) plays several key roles in the regulation of lipid and glucose homoeostasis. In this study, we investigated the potential role of SIRT1 in hyperuricemia and explored possible mechanisms. Significant hyperuricemia was detected in C57BL/6 mice treated with oxonate and yeast polysaccharide. Resveratrol (RSV), a specific SIRT1 activator, was administered to the mice. SIRT1 suppressed the increased serum uric acid level but up-regulated the expression of urate transporter ATP-binding cassette subfamily G member 2 (ABCG2) in the ileum of hyperuricemic mice. In a human colon carcinoma cell line, SIRT1 promoted ABCG2 production through the deacetylation of peroxisome proliferator-activated receptor (PPAR) γ co-activator 1α (PGC-1α), which then activated the effectors of PPARγ. Interestingly, the SIRT1-induced up-regulation of ABCG2 was significantly inhibited when PGC-1α or PPARγ was blocked by siRNA transfection. Our data demonstrated that SIRT1 and its activator, RSV, have clear anti-hyperuricemia functions in this mouse model. One possible mechanism is the activation of ABCG2 in the ileum through the PGC-1α/PPARγ pathway.

Entities:  

Keywords:  ABCG2; Hyperuricemia; PGC-1α; PPARγ; SIRT1

Mesh:

Substances:

Year:  2016        PMID: 27022940     DOI: 10.1007/s12020-016-0896-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  37 in total

Review 1.  Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease.

Authors:  Atsushi Enomoto; Hitoshi Endou
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

2.  ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans.

Authors:  Akiyoshi Nakayama; Hirotaka Matsuo; Tappei Takada; Kimiyoshi Ichida; Takahiro Nakamura; Yuki Ikebuchi; Kousei Ito; Tatsuo Hosoya; Yoshikatsu Kanai; Hiroshi Suzuki; Nariyoshi Shinomiya
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2011-12       Impact factor: 1.381

3.  Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity.

Authors:  Yong-Xu Wang; Chih-Hao Lee; Sambath Tiep; Ruth T Yu; Jungyeob Ham; Heonjoong Kang; Ronald M Evans
Journal:  Cell       Date:  2003-04-18       Impact factor: 41.582

4.  The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes.

Authors:  R B Vega; J M Huss; D P Kelly
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  PPARbeta/delta regulates the human SIRT1 gene transcription via Sp1.

Authors:  Mizuho Okazaki; Yasumasa Iwasaki; Mitsuru Nishiyama; Takafumi Taguchi; Makoto Tsugita; Shuichi Nakayama; Machiko Kambayashi; Kozo Hashimoto; Yoshio Terada
Journal:  Endocr J       Date:  2010-02-17       Impact factor: 2.349

6.  Mechanism of human SIRT1 activation by resveratrol.

Authors:  Margie T Borra; Brian C Smith; John M Denu
Journal:  J Biol Chem       Date:  2005-03-04       Impact factor: 5.157

7.  Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats.

Authors:  P Palsamy; S Subramanian
Journal:  Biomed Pharmacother       Date:  2008-07-09       Impact factor: 6.529

8.  Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ.

Authors:  Li Qiang; Liheng Wang; Ning Kon; Wenhui Zhao; Sangkyu Lee; Yiying Zhang; Michael Rosenbaum; Yingming Zhao; Wei Gu; Stephen R Farmer; Domenico Accili
Journal:  Cell       Date:  2012-08-03       Impact factor: 41.582

9.  The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha).

Authors:  Sylvia N Schreiber; Darko Knutti; Kathrin Brogli; Thomas Uhlmann; Anastasia Kralli
Journal:  J Biol Chem       Date:  2003-01-08       Impact factor: 5.157

10.  Nuclear receptor corepressors and PPARgamma.

Authors:  Ronald N Cohen
Journal:  Nucl Recept Signal       Date:  2006-02-08
View more
  9 in total

1.  Sirt1 inhibits gouty arthritis via activating PPARγ.

Authors:  Juan Wang; Guangliang Chen; Liangjing Lu; Hejian Zou
Journal:  Clin Rheumatol       Date:  2019-07-31       Impact factor: 2.980

Review 2.  As a Modulator, Multitasking Roles of SIRT1 in Respiratory Diseases.

Authors:  Yunxin Zhou; Fan Zhang; Junying Ding
Journal:  Immune Netw       Date:  2022-06-20       Impact factor: 5.851

Review 3.  Sirtuin deficiency and the adverse effects of fructose and uric acid synthesis.

Authors:  Bernardo Rodriguez-Iturbe; Richard J Johnson; Miguel A Lanaspa; Takahiko Nakagawa; Fernando E Garcia-Arroyo; Laura G Sánchez-Lozada
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-03-10       Impact factor: 3.619

4.  Resveratrol attenuates triglyceride accumulation associated with upregulation of Sirt1 and lipoprotein lipase in 3T3-L1 adipocytes.

Authors:  Haruki Imamura; Daiji Nagayama; Noriko Ishihara; Syo Tanaka; Rena Watanabe; Yasuhiro Watanabe; Yuta Sato; Takashi Yamaguchi; Noriko Ban; Hidetoshi Kawana; Masahiro Ohira; Kei Endo; Atsuhito Saiki; Kohji Shirai; Ichiro Tatsuno
Journal:  Mol Genet Metab Rep       Date:  2017-05-30

Review 5.  ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches.

Authors:  M C Cleophas; L A Joosten; L K Stamp; N Dalbeth; O M Woodward; Tony R Merriman
Journal:  Pharmgenomics Pers Med       Date:  2017-04-20

6.  Are the benefits of SGLT2 inhibitors in heart failure and a reduced ejection fraction influenced by background therapy? Expectations and realities of a new standard of care.

Authors:  Milton Packer
Journal:  Eur Heart J       Date:  2020-07-01       Impact factor: 29.983

Review 7.  Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugs.

Authors:  Milton Packer
Journal:  Cardiovasc Diabetol       Date:  2020-05-13       Impact factor: 9.951

8.  Zishen Qingre Tongluo Formula Improves Renal Fatty Acid Oxidation and Alleviated Fibrosis via the Regulation of the TGF-β1/Smad3 Signaling Pathway in Hyperuricemic Nephrology Rats.

Authors:  Peng Liu; Chen Wang; Yun Wang; Honghong Zhang; Baoli Liu; Xinping Qiu
Journal:  Biomed Res Int       Date:  2021-12-13       Impact factor: 3.411

9.  Triglycerides and Total Cholesterol Concentrations in Association with Hyperuricemia in Chinese Adults in Qingdao, China.

Authors:  Nan Cui; Jing Cui; Jianping Sun; Xinping Xu; Bilal Aslam; Lan Bai; Decheng Li; Di Wu; Zhongren Ma; Hai Gu; Zulqarnain Baloch
Journal:  Risk Manag Healthc Policy       Date:  2020-03-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.